ZVRA
ZEVRA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$11.17
+8.87%Forward multiples
Based on analyst estimates
- P/E forward
- 11.37x
- P/E 2026E
- 9.99x
- P/E 2027E
- 11.84x
- P/E 2028E
- 7.85x
- P/S forward
- 3.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 8.73x
- PEG TTM
- —
- Price / book
- 2.78x
- Price / sales
- 4.50x
- Price / cash flow
- 17.16x
Enterprise value
- Enterprise value
- $543.7M
- EV / sales
- 3.68x
- EV / EBITDA
- 6.54x
- EV / EBIT
- 11.69x
- Market cap
- $664.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026